Literature DB >> 17167071

Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus.

Ana P Silva1, Joana Lourenço, Sara Xapelli, Raquel Ferreira, Heidi Kristiansen, David P D Woldbye, Catarina R Oliveira, João O Malva.   

Abstract

The unbalanced excitatory/inhibitory neurotransmitter function in the neuronal network afflicted by seizures is the main biochemical and biophysical hallmark of epilepsy. The aim of this work was to identify changes in the signaling mechanisms associated with neuropeptide Y (NPY)-mediated inhibition of glutamate release that may contribute to hyperexcitability. Using isolated rat hippocampal nerve terminals, we showed that the KCl-evoked glutamate release is inhibited by NPY Y2 receptor activation and is potentiated by the stimulation of protein kinase C (PKC). Moreover, we observed that immediately after status epilepticus (6 h postinjection with kainate, 10 mg/kg), the functional inhibition of glutamate release by NPY Y2 receptors was transiently blocked concomitantly with PKC hyperactivation. The pharmacological blockade of seizure-activated PKC revealed again the Y2 receptor-mediated inhibition of glutamate release. The functional activity of PKC immediately after status epilepticus was assessed by evaluating phosphorylation of the AMPA receptor subunit GluR1 (Ser-831), a substrate for PKC. Moreover, NPY-stimulated [35S]GTPgammaS autoradiographic binding studies indicated that the common target for Y2 receptor and PKC on the inhibition/potentiation of glutamate release was located downstream of the Y2 receptor, or its interacting G-protein, and involves voltage-gated calcium channels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167071     DOI: 10.1096/fj.06-6163com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

Review 1.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

2.  Impact of protein kinase C activation on status epilepticus and epileptogenesis: oh, what a tangled web.

Authors:  Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2008 Jul-Aug       Impact factor: 7.500

3.  Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral density.

Authors:  K L Seldeen; P G Halley; C H Volmar; M A Rodríguez; M Hernandez; M Pang; S K Carlsson; L J Suva; C Wahlestedt; B R Troen; S P Brothers
Journal:  Neuropeptides       Date:  2017-11-07       Impact factor: 3.286

4.  Impact of protein kinase C activation on epileptiform activity in the hippocampal slice.

Authors:  Michaelangelo G Fuortes; Leonardo C Faria; Lisa R Merlin
Journal:  Epilepsy Res       Date:  2008-08-20       Impact factor: 3.045

5.  Activation of Neuropeptide Y2 Receptor Can Inhibit Global Cerebral Ischemia-Induced Brain Injury.

Authors:  Reggie Hui-Chao Lee; Celeste Yin-Chieh Wu; Cristiane T Citadin; Alexandre Couto E Silva; Harlee E Possoit; Garrett A Clemons; Christina H Acosta; Victoria A de la Llama; Jake T Neumann; Hung Wen Lin
Journal:  Neuromolecular Med       Date:  2021-05-21       Impact factor: 4.103

6.  FK506 Attenuated Pilocarpine-Induced Epilepsy by Reducing Inflammation in Rats.

Authors:  Aihua Wang; Zhihua Si; Xiaolin Li; Lu Lu; Yongli Pan; Jinzhi Liu
Journal:  Front Neurol       Date:  2019-09-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.